Additionally, inhibition of key inflammatory kinases, including IκB kinase ε (IKKε) and TANK-binding kinase 1 (TBK1), using compounds such as amlexanox, has been shown to restore catecholamine sensitivity and reverse metabolic dysfunctions associated with obesity [31]. The gene discussed is TBK1; the disease is obesity disorder.